Search results (112)
« Back to PublicationsInterleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.
Gharahdaghi N. et al, (2026), The New England journal of medicine, 394, 2212 - 2222
Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries.
Schreiber S. et al, (2026), United European gastroenterology journal, 14
A single centre real-world study of Risankizumab in Crohn's disease
Tan CK. et al, (2026), JOURNAL OF CROHNS & COLITIS, 20
Etrasimod Real-World Experience in Ulcerative Colitis: A multicentre cohort study
Vayreda E. et al, (2026), JOURNAL OF CROHNS & COLITIS, 20
Factors associated with hospitalisations, emergency visits and related costs in inflammatory bowel disease: insights from the TrueColours-IBD digital monitoring programme in Oxford
Fierens L. et al, (2026), JOURNAL OF CROHNS & COLITIS, 20
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.
Lee SD. et al, (2025), The American journal of gastroenterology, 120, 2857 - 2866
Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers.
Dubinsky M. et al, (2025), The American journal of gastroenterology
Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study.
Radia C. et al, (2025), Journal of Crohn's & colitis, 19
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.
Regueiro M. et al, (2025), Journal of Crohn's & colitis, 19
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey.
Fiorino G. et al, (2025), Journal of Crohn's & colitis, 19
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab.
Clemow DB. et al, (2025), Journal of patient-reported outcomes, 9
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey.
Fiorino G. et al, (2025), Journal of Crohn's & colitis, 19
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.
Panaccione R. et al, (2025), Crohn's & colitis 360, 7
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres.
Young D. et al, (2025), Drugs in context, 14